The trading price of Abbvie Inc (NYSE:ABBV) closed higher on Tuesday, July 08, and closing at $189.77, 1.14% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $186.67 and $193.0. The company’s P/E ratio in the trailing 12-month period was 80.92, while its 5Y monthly beta was 0.491. In examining the 52-week price action we see that the stock hit a 52-week high of $218.66 and a 52-week low of $163.81. Over the past month, the stock has gained 1.23% in value.
Abbvie Inc, whose market valuation is $335.21 billion at the time of this writing, is expected to release its quarterly earnings report on 2025-Apr-25. The dividend yield on the company stock is 3.36%, while its Forward Dividend ratio is 6.38. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest ABBV has a Hold on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 50% Buy.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned ABBV a recommendation rating is 27. Out of them, 7 rate it a Hold, while 20 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Abbvie Inc (ABBV) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
If we dig deeper into the stock’s outlook, we see that the stock’s PEG is 5.31, which symbolizes a positive outlook. A quick review shows that ABBV’s price is currently 1.01% off the SMA20 and 1.19% off the SMA50. The RSI metric on the 14-day chart is currently showing 54.56, and weekly volatility stands at 2.56%. When measured over the past 30 days, the indicator reaches 2.12%. Abbvie Inc (NYSE:ABBV)’s beta value is currently sitting at 0.50. With analysts defining $215-$220 as the low and high price targets, we arrive at a consensus price target of $217.5 for the trailing 12-month period. The current price is about -13.3% off the estimated low and -15.93% off the forecast high, based on this estimate. Investors will be thrilled if ABBV’s share price rises to $217.5, which is the median consensus price. At that level, ABBV’s share price would be -14.61% below current price.
To see how Abbvie Inc stock has been performing in comparison to its peers in the industry, here are the numbers: ABBV stock’s performance was 1.14% in the latest trading, and 6.79% in the past year. Abbvie Inc has a P/E ratio of 80.92.
An evaluation of the daily trading volume of Abbvie Inc (NYSE:ABBV) indicates that the 3-month average is 7.47 million. However, this figure has increased over the past 10 days to an average of 8.25.
Currently, records show that 1.77 billion of the company’s shares remain outstanding. The insiders hold 0.09% of outstanding shares, whereas institutions hold 74.08%. The stats also highlight that short interest as of 2025-06-13, stood at 14.7 million shares, resulting in a short ratio of 2.5 at that time. From this, we can conclude that short interest is 83.00 of the company’s total outstanding shares. It is noteworthy that short shares in June were down slightly from the previous month’s figure, which was 19.93 million. However, since the stock’s price has seen 15.83% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
